human | Q5 |
P213 | ISNI | 0000000078023991 |
P244 | Library of Congress authority ID | no2010061435 |
P2798 | Loop ID | 429323 |
P496 | ORCID iD | 0000-0002-3316-1471 |
P1053 | ResearcherID | G-8398-2018 |
P2038 | ResearchGate profile ID | Ildefonso_Rodriguez-Leyva |
P1153 | Scopus author ID | 16043882200 |
P214 | VIAF ID | 120549993 |
P10832 | WorldCat Entities ID | E39PBJjmT8QPJ6tD9DgxGqFR8C |
P27 | country of citizenship | Mexico | Q96 |
P69 | educated at | Autonomous University of San Luis Potosí | Q7894242 |
P108 | employer | Massachusetts General Hospital | Q126412 |
Autonomous University of San Luis Potosí | Q7894242 | ||
Hospital Central Dr. Ignacio Morones Prieto | Q29054809 | ||
P735 | given name | Ildefonso | Q3796357 |
Ildefonso | Q3796357 | ||
P106 | occupation | researcher | Q1650915 |
P551 | residence | San Luis Potosí | Q78980 |
P21 | sex or gender | male | Q6581097 |
P2031 | work period (start) | 1987-01-01 |
Q37335864 | A common haplotype within the PON1 promoter region is associated with sporadic ALS. |
Q92846521 | A novel disposable sensor for measure intra-abdominal pressure |
Q33963019 | Effect of vigabatrin on the pharmacokinetics of carbamazepine |
Q33661884 | Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial |
Q53742122 | EpiNet as a way of involving more physicians and patients in epilepsy research: Validation study and accreditation process. |
Q28143122 | Exposure to arsenic and lead and neuropsychological development in Mexican children |
Q90177099 | Extended-release vinpocetine: a possible adjuvant treatment for focal onset epileptic seizures |
Q47943598 | Fluorescence background removal method for biological Raman spectroscopy based on empirical mode decomposition. |
Q100439373 | Hemichorea-Hemiballism: An Uncommon Presentation of Central Nervous System Tuberculosis |
Q60912571 | Late onset adrenoleukodystrophy: A review related clinical case report |
Q93175431 | Low levels of alpha-synuclein in peripheral tissues are related to clinical relapse in relapsing-remitting multiple sclerosis: a pilot cross-sectional study |
Q46717008 | New VAPB deletion variant and exclusion of VAPB mutations in familial ALS. |
Q41312269 | Oxidative Stress Modifies the Levels and Phosphorylation State of Tau Protein in Human Fibroblasts. |
Q34155982 | Paraoxonase gene mutations in amyotrophic lateral sclerosis |
Q36639646 | Parkinson disease and progressive supranuclear palsy: protein expression in skin. |
Q90192013 | Perinuclear Lamin A and Nucleoplasmic Lamin B2 Characterize Two Types of Hippocampal Neurons through Alzheimer's Disease Progression |
Q89955989 | Population Pharmacokinetics and Dosing Recommendations of Levetiracetam in Adult and Elderly Patients With Epilepsy |
Q30442798 | Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate |
Q28943310 | Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis |
Q48303426 | Skin biomarkers for neurodegenerative disease: a future perspective. |
Q42683308 | Tau Protein in Oral Mucosa and Cognitive State: A Cross-sectional Study |
Q59576415 | The Presence of Alpha-Synuclein in Skin from Melanoma and Patients with Parkinson's Disease |
Q50104927 | The resurgence of meningeal tuberculosis in Mexico: A social phenomenon. |
Q46131276 | Use of statins for the treatment of spontaneous intracerebral hemorrhage: results of a pilot study. |
Q34286993 | α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism |
Search more.